跳至主要内容
临床试验/CTRI/2023/10/059184
CTRI/2023/10/059184尚未招募3 期

Cytoreductive surgery and HIPEC in relapsed epithelial ovarian cancer – a phase III randomised control trial and descriptive study to evaluate effect of HIP3C in HRD/BRCAwt genomic profile - nil

BR Ambedkar Institute Rotary Cancer Hospital BRAIRCH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients with recurrent epithelial ovarian cancer
  • 2.Biochemical, radiological or clinical recurrence
  • 3.Patients satisfying the selection criteria score of >6 taking into account the parameters mentioned in the following table.
  • ComponentsScore
  • Performance status03
  • Optimized 21
  • Progression free Interval >18 mo3
  • Prior optimal CRSCC-03
  • CA 125 at relapseNormal1
  • Symptomatic statusAsymptomatic1
  • Symptomatic0

排除标准

  • 1.Platinum resistant disease
  • 2.Patients who have received chemotherapy after detection of recurrence
  • 3. Extraabdominal recurrent disease

研究者

发起方
BR Ambedkar Institute Rotary Cancer Hospital BRAIRCH

相似试验